Contineum Therapeutics
PIPE-307, a monoclonal antibody mAChR1 antagonist for CNS demyelinating disease treatment
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 13 pending · first 2024
- Rank in peer group#339 of 1449
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#339 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 3 granted of 16- PendingMuscarinic Acetylcholine M1 Receptor AntagonistsUSPTOApplication 19451835
- GrantedMuscarinic Acetylcholine M1 Receptor AntagonistsUSPTOUS 12,565,501
- GrantedMuscarinic Acetylcholine M1 Receptor AntagonistsUSPTOUS 12,390,462
Show all 16 patent records
- Muscarinic Acetylcholine M1 Receptor AntagonistsMay 21, 2026 · Application 19451835Pending
- Muscarinic Acetylcholine M1 Receptor AntagonistsMar 3, 2026 · US 12,565,501Granted
- Muscarinic Acetylcholine M1 Receptor AntagonistsAug 19, 2025 · US 12,390,462Granted
- LPAR1 Antagonists And Uses ThereofJun 5, 2025 · Application 18294513Pending
- Muscarinic Acetylcholine M1 Receptor AntagonistsMay 29, 2025 · Application 19030481Pending
- LPAR1 Antagonists And Uses ThereofJan 30, 2025 · Application 18294515Pending
- Muscarinic Acetylcholine M1 Receptor AntagonistsJan 23, 2025 · Application 18747272Pending
- Muscarinic Acetylcholine M1 Receptor AntagonistsAug 6, 2024 · US 12,054,487Granted
- Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor AntagonistsJul 4, 2024 · Application 18286088Pending
- Crystalline Compound Of An LPAR1 AntagonistApplication PCTUS2024013232Pending
- Methods Of Treating Depression Using A Muscarinic Acetylcholine Receptor M1 AntagonistApplication 63720561Pending
- Peripherally Restricted LPAR1 Antagonists And Uses ThereofApplication PCTUS2025019389Pending
- LPAR1 Antagonists And Uses ThereofApplication PCTUS2022039466Pending
- LPAR1 Antagonists And Uses ThereofApplication PCTUS2022039465Pending
- Crystalline Compound Of An LPAR1 AntagonistApplication 19148979Pending
- Peripherally Restricted LPAR1 Antagonists And Uses ThereofApplication 63564423Pending
Related companies, and why
- Scholar RockSimilar federal contract value in Biotech · null in contracts
- SeaStar Medical, Inc.Similar federal contract value in Biotech · null in contracts
- SynthorxSimilar federal contract value in Biotech · null in contracts
- Pulmatrix Operating Company, Inc.Similar federal contract value in Biotech · null in contracts
- Tarsa Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Pasithea Therapeutics Corp.Similar federal contract value in Biotech · null in contracts
Press
J&J’s Contineum-partnered depression drug flunks another phase 2 testFierceBiotech
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .